BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 18268940)

  • 1. A pilot study of inspiratory capacity and resting dyspnea correlations in exacerbations of COPD and asthma.
    Pretto JJ; McMahon MA; Rochford PD; Berlowitz DJ; Jones SM; Brazzale DJ; McDonald CF
    Int J Chron Obstruct Pulmon Dis; 2007; 2(4):651-6. PubMed ID: 18268940
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Static and dynamic hyperinflation during severe acute exacerbations of chronic obstructive pulmonary disease.
    van Geffen WH; Kerstjens HA
    Int J Chron Obstruct Pulmon Dis; 2018; 13():1269-1277. PubMed ID: 29713160
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Measurement of symptoms, lung hyperinflation, and endurance during exercise in chronic obstructive pulmonary disease.
    O'Donnell DE; Lam M; Webb KA
    Am J Respir Crit Care Med; 1998 Nov; 158(5 Pt 1):1557-65. PubMed ID: 9817708
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inspiratory drive is related to dynamic pulmonary hyperinflation in COPD patients.
    Gatta D; Fredi M; Aliprandi G; Pini L; Tantucci C
    Int J Chron Obstruct Pulmon Dis; 2013; 8():169-73. PubMed ID: 23569371
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of long-acting bronchodilators and prednisolone on inspiratory lung function parameters in stable COPD.
    Ramlal SK; Visser FJ; Hop WC; Dekhuijzen PN; Heijdra YF
    Pulm Pharmacol Ther; 2014 Aug; 28(2):158-64. PubMed ID: 24076367
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low resting diffusion capacity, dyspnea, and exercise intolerance in chronic obstructive pulmonary disease.
    Elbehairy AF; O'Donnell CD; Abd Elhameed A; Vincent SG; Milne KM; James MD; Webb KA; Neder JA; O'Donnell DE;
    J Appl Physiol (1985); 2019 Oct; 127(4):1107-1116. PubMed ID: 31369329
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inspiratory capacity and forced expiratory volume in the first second in exacerbation of chronic obstructive pulmonary disease.
    Yetkin O; Gunen H
    Clin Respir J; 2008 Jan; 2(1):36-40. PubMed ID: 20298302
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of tiotropium on hyperinflation and treadmill exercise tolerance in mild to moderate chronic obstructive pulmonary disease.
    Casaburi R; Maltais F; Porszasz J; Albers F; Deng Q; Iqbal A; Paden HA; O'Donnell DE;
    Ann Am Thorac Soc; 2014 Nov; 11(9):1351-61. PubMed ID: 25289942
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inspiratory fraction and exercise impairment in COPD patients GOLD stages II-III.
    Albuquerque AL; Nery LE; Villaça DS; Machado TY; Oliveira CC; Paes AT; Neder JA
    Eur Respir J; 2006 Nov; 28(5):939-44. PubMed ID: 16870665
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic responses in asthma and COPD. Bronchodilators.
    Donohue JF
    Chest; 2004 Aug; 126(2 Suppl):125S-137S; discussion 159S-161S. PubMed ID: 15302773
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Randomized controlled trial of a breath-activated nebulizer in patients with exacerbation of COPD.
    Haynes JM
    Respir Care; 2012 Sep; 57(9):1385-90. PubMed ID: 22348309
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Changes in inspiratory capacity during acute respiratory failure in COPD patients].
    Lemasson S; Nesme P; Herblanc A; Beuret P; Louérat C; Bourdin G; Vargas F; Guérin JC; Hilbert G; Guérin C
    Rev Mal Respir; 2007 Mar; 24(3 Pt 1):314-22. PubMed ID: 17417169
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tiotropium bromide. A review of its use as maintenance therapy in patients with COPD.
    Keam SJ; Keating GM
    Treat Respir Med; 2004; 3(4):247-68. PubMed ID: 15350163
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improvement in resting inspiratory capacity and hyperinflation with tiotropium in COPD patients with increased static lung volumes.
    Celli B; ZuWallack R; Wang S; Kesten S
    Chest; 2003 Nov; 124(5):1743-8. PubMed ID: 14605043
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improved respiratory system conductance following bronchodilator predicts reduced exertional dyspnoea.
    Diba C; King GG; Berend N; Salome CM
    Respir Med; 2011 Sep; 105(9):1345-51. PubMed ID: 21482091
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Measurement of Dynamic Hyperinflation During the 6-Minute Walk Test Using a Mobile Device.
    Meys R; Schiefer M; de Nijs SB; Bindels H; de Kruif MD
    Respir Care; 2019 Feb; 64(2):182-188. PubMed ID: 30584067
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lung mechanics and dyspnea during exacerbations of chronic obstructive pulmonary disease.
    Stevenson NJ; Walker PP; Costello RW; Calverley PM
    Am J Respir Crit Care Med; 2005 Dec; 172(12):1510-6. PubMed ID: 16166620
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparing dynamic hyperinflation and associated dyspnea induced by metronome-paced tachypnea versus incremental exercise.
    Calligaro GL; Raine RI; Bateman ME; Bateman ED; Cooper CB
    COPD; 2014 Feb; 11(1):105-12. PubMed ID: 24152211
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decline of resting inspiratory capacity in COPD: the impact on breathing pattern, dyspnea, and ventilatory capacity during exercise.
    O'Donnell DE; Guenette JA; Maltais F; Webb KA
    Chest; 2012 Mar; 141(3):753-762. PubMed ID: 21852298
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reversibility of inspiratory lung function parameters after short-term bronchodilators in COPD.
    Ramlal SK; Visser FJ; Hop WC; Dekhuijzen PN; Heijdra YF
    Respir Physiol Neurobiol; 2010 Aug; 173(1):58-63. PubMed ID: 20601207
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.